MicroRNA-143 replenishment re-sensitizes colorectal cancer cells harboring mutant, but not wild-type, KRAS to paclitaxel treatment
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-143 replenishment re-sensitizes colorectal cancer cells harboring mutant, but not wild-type, KRAS to paclitaxel treatment
Authors
Keywords
Colorectal cancer, KRAS, miR-143, let-7b
Journal
TUMOR BIOLOGY
Volume 37, Issue 5, Pages 5829-5835
Publisher
Springer Nature
Online
2015-11-18
DOI
10.1007/s13277-015-4354-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Let-7b expression determines response to chemotherapy through the regulation of Cyclin D1 in Glioblastoma
- (2013) Yong Guo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Let-7c Governs the Acquisition of Chemo- or Radioresistance and Epithelial-to-Mesenchymal Transition Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma
- (2013) Shi-Yun Cui et al. MOLECULAR CANCER RESEARCH
- Purvalanol A, Olomoucine II and Roscovitine Inhibit ABCB1 Transporter and Synergistically Potentiate Cytotoxic Effects of Daunorubicin In Vitro
- (2013) Daniela Cihalova et al. PLoS One
- Epigenetic and genetic features of 24 colon cancer cell lines
- (2013) D Ahmed et al. Oncogenesis
- MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer
- (2012) S Ali et al. BRITISH JOURNAL OF CANCER
- Let-7 Expression Is a Significant Determinant of Response to Chemotherapy through the Regulation of IL-6/STAT3 Pathway in Esophageal Squamous Cell Carcinoma
- (2012) K. Sugimura et al. CLINICAL CANCER RESEARCH
- Practice Parameters for the Management of Colon Cancer
- (2012) George J. Chang et al. DISEASES OF THE COLON & RECTUM
- Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression
- (2012) A Pagliuca et al. ONCOGENE
- MicroRNA-302 Increases Reprogramming Efficiency via Repression of NR2F2
- (2012) Shijun Hu et al. STEM CELLS
- Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non–Small-Cell Lung Cancer (NSCLC)
- (2011) Thanyanan Reungwetwattana et al. Clinical Lung Cancer
- Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1
- (2011) Benjamin Boyerinas et al. INTERNATIONAL JOURNAL OF CANCER
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS
- (2011) Bin Xu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
- (2011) Phong Trang et al. MOLECULAR THERAPY
- Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
- (2010) O. A. Kent et al. GENES & DEVELOPMENT
- Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
- (2010) Marc Peeters et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
- (2010) Jean-Yves Douillard et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of let-7 in cell differentiation and cancer
- (2009) Benjamin Boyerinas et al. ENDOCRINE-RELATED CANCER
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of miR-143 targeting KRAS in colorectal tumorigenesis
- (2009) X Chen et al. ONCOGENE
- Regression of murine lung tumors by the let-7 microRNA
- (2009) P Trang et al. ONCOGENE
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
- (2008) Carsten Bokemeyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Oct4/Sox2-Regulated miR-302 Targets Cyclin D1 in Human Embryonic Stem Cells
- (2008) D. A. Greer Card et al. MOLECULAR AND CELLULAR BIOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now